Page 1 of 2 No. ACC1903/001 March 1, 2019 Subject: Approval to enter into Contract to sell of Common Stock (addition) To: President The Stock Exchange of Thailand According to the Board of Director’s
Page 1 of 3 No. ACC1903/001 March 1, 2019 Subject: Approval to enter into Contract to sell of Common Stock (additional 2) To: President The Stock Exchange of Thailand According to the Board of
investment type as follows: 1. Bank Deposit 2. GSB/BAAC Lottery 3. Common Stock 4. Real Estates 5. Precious Metal 6. Personal Share 7. Insurance Policy 8. Cooperatives 9. Government Bond 10. State Enterprise
. - Additional shares can be subscribed by existing shareholders including AEONTS have pre- emptive rights to subscribe the additional issuance of new common shares in proportion of 80% which is an existing shares
. - Additional shares can be subscribed by existing shareholders including AEONTS have pre- emptive rights to subscribe the additional issuance of new common shares in proportion of 80% which is an existing shares
Company expected to generate more revenue from rent and service in the long run. (2) The Company recorded total costs and expenses of THB 662.05 million, decrease by THB 1.70 million or 0.26%. The
and 2 attached herewith. The OFAR system will be available for a test run during 1-30 December 2016. Thereafter, intermediaries will be required to submit their daily status report via OFAR, starting
and 2 attached herewith. The OFAR system will be available for a test run during 1-30 December 2016. Thereafter, intermediaries will be required to submit their daily status report via OFAR, starting
or Baht 9.0 million because of annual salaries adjustment and a factory testing run cost incurred out of our subsidiary L&E Vietnam; -and a lower CIT Baht 1.5 million Y-O-Y mainly from decrease of the
transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65